IRIS
GARRIBBA, Eugenio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.019
AS - Asia 6.397
SA - Sud America 3.634
EU - Europa 3.309
Continente sconosciuto - Info sul continente non disponibili 384
AF - Africa 262
OC - Oceania 17
Totale 26.022
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.728
BR - Brasile 3.225
SG - Singapore 2.678
CN - Cina 1.773
UA - Ucraina 1.158
HK - Hong Kong 609
DE - Germania 488
VN - Vietnam 419
SE - Svezia 329
IT - Italia 288
FI - Finlandia 249
FR - Francia 242
GB - Regno Unito 193
AR - Argentina 136
TR - Turchia 131
BD - Bangladesh 126
MX - Messico 116
CA - Canada 102
IN - India 96
IQ - Iraq 90
RU - Federazione Russa 75
ZA - Sudafrica 67
EC - Ecuador 65
VE - Venezuela 60
JP - Giappone 57
UZ - Uzbekistan 57
MA - Marocco 56
CO - Colombia 51
PL - Polonia 46
ID - Indonesia 44
ES - Italia 41
PK - Pakistan 41
NL - Olanda 39
KR - Corea 33
KE - Kenya 29
PY - Paraguay 28
AZ - Azerbaigian 25
JO - Giordania 24
JM - Giamaica 22
OM - Oman 22
UY - Uruguay 22
AE - Emirati Arabi Uniti 20
BE - Belgio 20
NP - Nepal 20
CL - Cile 19
CZ - Repubblica Ceca 19
PE - Perù 19
SA - Arabia Saudita 18
EG - Egitto 17
KZ - Kazakistan 17
TN - Tunisia 17
DZ - Algeria 16
PH - Filippine 16
AT - Austria 15
AU - Australia 15
HN - Honduras 15
RS - Serbia 13
LT - Lituania 12
SN - Senegal 11
BY - Bielorussia 10
IL - Israele 10
AO - Angola 9
MY - Malesia 9
CH - Svizzera 8
CR - Costa Rica 8
DO - Repubblica Dominicana 8
EU - Europa 8
LB - Libano 8
PS - Palestinian Territory 8
GA - Gabon 7
GR - Grecia 7
PT - Portogallo 7
RO - Romania 7
AL - Albania 6
BO - Bolivia 6
CG - Congo 6
ET - Etiopia 6
GE - Georgia 6
IE - Irlanda 6
KG - Kirghizistan 6
NG - Nigeria 6
AM - Armenia 5
BA - Bosnia-Erzegovina 5
QA - Qatar 5
BG - Bulgaria 4
EE - Estonia 4
IR - Iran 4
PA - Panama 4
SY - Repubblica araba siriana 4
TH - Thailandia 4
TW - Taiwan 4
CI - Costa d'Avorio 3
GT - Guatemala 3
HU - Ungheria 3
MD - Moldavia 3
MK - Macedonia 3
NI - Nicaragua 3
SI - Slovenia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BW - Botswana 2
Totale 25.609
Salva come PNG Salva come JPEG
Città #
Dallas 3.999
Singapore 1.454
Chandler 1.222
San Jose 1.009
Jacksonville 671
Hong Kong 601
Ashburn 509
Princeton 415
Council Bluffs 367
Beijing 336
Columbus 307
Nanjing 256
São Paulo 240
Dearborn 235
Lauterbourg 203
Wilmington 183
Ho Chi Minh City 144
Shanghai 140
Santa Clara 135
Boardman 118
Hanoi 108
Los Angeles 103
Nanchang 97
Rio de Janeiro 91
Ann Arbor 86
Belo Horizonte 84
New York 80
Tianjin 80
Helsinki 71
Woodbridge 66
Shenyang 64
Brasília 58
Tokyo 54
Hebei 53
Tashkent 53
Sassari 50
The Dalles 49
Changsha 47
Curitiba 47
Frankfurt am Main 47
Jiaxing 46
San Francisco 45
Campinas 44
Baghdad 39
Izmir 39
Mountain View 37
Warsaw 37
Jinan 35
Norwalk 35
Falls Church 34
Hangzhou 32
Porto Alegre 32
Salvador 32
Zhengzhou 32
Montreal 31
Orem 31
Atlanta 30
Johannesburg 30
Kunming 30
Seoul 30
Buffalo 29
Ningbo 29
Amsterdam 28
Andover 28
Toronto 28
Mexico City 27
Munich 27
Campo Grande 26
Denver 26
Dhaka 26
Guarulhos 26
Santo André 26
Baku 25
Brooklyn 25
Milan 25
Nairobi 25
São José dos Campos 25
Falkenstein 24
London 24
Phoenix 24
Amman 23
Houston 23
Sorocaba 23
Chennai 22
Chicago 22
Goiânia 22
Quito 22
Ribeirão Preto 21
Haiphong 20
Manaus 20
Montevideo 20
Recife 20
Stockholm 20
Brussels 19
Caracas 19
Fortaleza 19
Guangzhou 19
Istanbul 18
Jakarta 18
Muscat 18
Totale 15.564
Salva come PNG Salva come JPEG
Nome #
Speciation and structural transformation of a VV–malate complex in the absence and in the presence of a protein: from a dinuclear species to decavanadate 294
Controlling intramolecular electronic communication through the conformation changes via stepwise oxidations in dicopper(ii) and dinickel(ii) porphyrin dimers 243
Exploiting the potential of rivastigmine-melatonin derivatives as multitarget metal-modulating drugs for neurodegenerative diseases 236
Bioinspired Oxidized Dicobalt Porphyrin Dimer-Catalyzed Cycloaddition Reactions: Cooperative Catalysis and Spectroscopic and Mechanistic Investigation 198
A Multi-Technique Investigation of the Complex Formation Equilibria between Bis-Deferiprone Derivatives and Oxidovanadium (IV) 184
Co-ordination Ability of Cu2+ ion toward the Nucleobase-Amino Acid Willardiine 183
A hexanucluear copper(II) Schiff base complex incorporating rare “bicapped cubane” core: Structural aspects, magnetic properties and EPR study 180
A 2-D coordination polymer incorporating cobalt(II), 2-sulfoterephthalate and the flexible bridging ligand 1,3-di(4-pyridyl)propane 169
5,5′-Dibenzoimidazole as building block for a new 3D Co(II) coordination polymer: A combined EPR and DFT study using UB3LYP model 162
Binding of oxovanadium(IV) to imidazole, pyrazole and thiazole ligands 157
A trigonal prismatic anionic iron(III) complex of a radical o-iminobenzosemiquinonate derivative: Structural and spectral analyses 157
A novel μ1,1-azido-, μ2-alkoxo-, and μ2-phenoxo-bridged tetranuclear copper(II) complex with a quinquedentate Schiff-base ligand: magneto-structural and DFT studies 156
A novel mixed valent CuII–CuI 2D framework made of a hydrazone and μ-SCN bridged metallacyclic loops cross-linked by μ3-SCN chains 155
Vanadium(IV,V) complexes of D-saccharic and mucic acids in aqueous solution 152
A Ni(II) derivative incorporating tetradentate Schiff base precursor: Structure, spectral, electrochemical and DFT interpretation 151
End-to-end thiocyanato-bridged zig-zag polymers of CuII, CoII and NiII with a hydrazone ligand: EPR, magnetic susceptibility and biological study 150
A New CuII Coordination Polymer: Structural Elucidation, EPR and Sensing Studies for Detection of Volatile Organic Solvents 148
Biorelevant reactions of the potential anti-tumor agent vanadocene dichloride 147
A rare cobalt(III) paramagnetic derivative incorporating 1-alkyl-2-[(o-thioalkyl)phenylazo]imidazole (SMeaaiNEt): EPR, redox and magnetic interpretation 147
Behavior of the potential antitumor VIVO complexes formed by flavonoid ligands. 1. Coordination modes and geometry in solution and at the physiological pH 147
A mixed valent heterometallic Cu-II/Na-I coordination polymer with sodium–phenyl bonds 146
Temperature and solvent structure dependence of VO2+ complexes of pyridine-N-oxide derivatives and their interaction with human serum transferrin 145
Binding of VIVO2+ to the Fe binding sites of human serum transferrin. A theoretical study 144
Synthesis of Two New Linear Trinuclear CuII Complexes: Mechanism of Magnetic Coupling through Hybrid B3LYP Functional and CShM Studies 143
A Trimetallic Cu(II) Derivative as an Efficient and Stable Electrocatalyst for Reduction of Proton to Molecular Hydrogen 143
A new linear double phenoxide-bridged trinuclear Cu(II) Schiff base complex: Synthesis, crystallographic elucidation, magneto-structural 141
Chemistry of mixed-ligand oxidovanadium(IV) complexes of aroylhydrazones incorporating quinoline derivatives: Study of solution behavior, theoretical evaluation and protein/DNA interaction 141
Synthesis and characterization of vanadium(IV) complexes with cis-inositol in aqueous solution and in the solid-state 140
Covalent and non-covalent binding in vanadium–protein adducts 140
A Ni(II) dinuclear complex bridged by end-on azide-N and phenolate-O atoms: spectral interpretation, magnetism and biological study 140
A quantitative study of the biotransformation of insulin-enhancing VO(2+) compounds 139
Electron Shuttling in High-Valent Heterobimetallic NiFe-Porphyrin Dimers: Stabilization of Ni(III) and Fe-Phenoxyl Radicals 138
Speciation of potential anti-diabetic vanadium complexes in real serum samples 138
An enolato-bridged dinuclear Cu(II) complex with a coumarin-assisted precursor: a spectral, magnetic and biological study 135
Speciation in aqueous solution and interaction with low and high molecular mass blood bioligands of [VIVO(oda)(H2O)2], a V compound with in vitro anticancer activity 135
Elucidation of Binding Site and Chiral Specificity of Oxidovanadium Drugs with Lysozyme through Theoretical Calculations 134
Chemistry of oxidomolybdenum(IV) and -(VI) complexes with ONS donor ligands: Synthesis, computational evaluation and oxo-transfer reactions 134
Synthesis of Nitric Oxide Donors Derived from Piloty’s Acid and Study of Their Effects on Dopamine Secretion from PC12 Cells 134
Binding of Oxovanadium(IV) to Dipeptides containing Histidine and Cysteine Residues 133
DFT Protocol for EPR Prediction of Paramagnetic Cu(II) Complexes and Application to Protein Binding Sites 133
Interaction of antidiabetic vanadium compounds with hemoglobin and red blood cells and their distribution between plasma and erythrocytes 133
Formation of Mixed‐Valence Cage‐Like Polyoxidovanadates at 37°C Upon Reaction of VIVO(acetylacetonato)2 With Lysozyme 132
Binding of potential antitumor Casiopeínas® to small proteins 132
A new Ni(II) coordination polymer formed by bulky bis(imidazole) and 4,4′-oxybis(benzoic acid): Topological and spectral elucidation 132
A New phenoxido/trifluoroacetato bridged heterometallic Ni II2 –Cu II derivative: Structure, EPR interpretation and DFT computation 131
ESI-MS Study of the Interaction of Potential Oxidovanadium(IV) Drugs and Amavadin with Model Proteins 131
Nonoxido VIV complexes: Prediction of the EPR spectrum and electronic structure of simple coordination compounds and amavadin 130
Antitumoral effect of vanadium compounds in malignant melanoma cell lines 129
Biospeciation of Potential Vanadium Drugs of Acetylacetonate in the Presence of Proteins 129
Simple Coordination Geometry Descriptors Allow to Accurately Predict Metal-Binding Sites in Proteins 129
Cobalt(II), manganese(IV) mononuclear and zinc(II) symmetric dinuclear complexes of an aliphatic hydrazone Schiff base ligand with diversity in coordination behaviors and supramolecular architectures: syntheses, structural elucidations, and spectroscopic characterizations 127
Complex formation between [(η6-p-cym)Ru(H2O)3]2+ and oligopeptides containing three histidyl moieties 127
Vanadium and proteins: Uptake, transport, structure,activity and function 125
Oxovanadium(IV) binding to ligands containing donor sites of biological relevance 125
Integrated ESI-MS/EPR/computational characterization of the binding of metal species to proteins: vanadium drug–myoglobin application 124
Physicochemical, antioxidant, DNA cleaving properties and antimicrobial activity of fisetin-copper chelates 124
Binding of VIV O2+ , VIV OL, VIV OL2 and VV O2 L Moieties to Proteins: X-ray/Theoretical Characterization and Biological Implications 123
VIVO Complexes of Bis(imidazol-2-yl) Derivatives: a Potentiometric, Spectroscopic and DFT Study 122
Synthesis, structure, physicochemical characterization and theoretical evaluation of non-covalent interaction energy of a polymeric copper(II)-hydrazone complex 122
Bis- and tris(pyridyl)amine-oxidovanadium complexes: characteristics and insulin-mimetic potential 121
Antiproliferative activity of vanadium compounds: Effects on the major malignant melanoma molecular pathways 121
Electronic structure of oxovanadium(IV) complexes of alpha-hydroxycarboxylic acids 120
Speciation in human blood of Metvan, a vanadium based potential anti-tumor drug 120
Solution speciation and spectral studies on oxovanadium(IV) complexes of pyridinecarboxylic acids 119
Rationalizing the Decavanadate(V) and Oxidovanadium(IV) Binding to G-Actin and the Competition with Decaniobate(V) and ATP 119
Coordination modes of hydroxamic acids in copper(II), nickel(II) and zinc(II) mixed-ligand complexes in aqueous solution 118
Accurate prediction of vertical electronic transitions of Ni(II) coordination compounds via time dependent density functional theory 118
Effect of temperature and ligand protonation on the electronic ground state in Cu(ii) polymers having unusual secondary interactions: a magnetic and catechol oxidase study 118
Effect of secondary interactions, steric hindrance and electric charge on the interaction of VIVO species with proteins 117
The equilibrium between the octahedral and square pyramidal form in VIVO complexes and the influence of an axial ligand on their molecular properties: a spectroscopic and DFT study 117
V(IV)O complexes with bis(pyridyl) derivatives 116
A rare doubly nitrato and phenoxido bridged trimetallic CuIIcomplex: EPR, antiferromagnetic coupling and theoretical rationalization 116
Structural elucidation, EPR and magnetic property of a Co(III) complex salt incorporating 4,4′-bipyridine and 5-sulfoisophthalate 116
Interaction of a chelating agent, 5-hydroxy-2-(hydroxymethyl)pyridin-4(1 H )-one, with Al(III), Cu(II) and Zn(II) ions 116
Exploring polyoxidovanadate–protein interaction 115
Chelating properties of EDTA-type ligands containing six-membered backbone ring toward copper ion: Structure, EPR and TD-DFT evaluation 115
Interaction of VO2+ ion with human serum transferrin and albumin 115
Ferromagnetic exchange coupling in a new bis(l-chloro)-bridged copper(II) Schiff base complex: synthesis, structure, magnetic properties and catalytic oxidation of cycloalkanes 114
The determination of the geometry of Cu(II) complexes - An EPR spectroscopy experiment 114
Role of Ligands in the Uptake and Reduction of V(V) Complexes in Red Blood Cells 114
Antiproliferative activity of vanadium compounds: Effects on the major malignant melanoma molecular pathways 114
Behavior of the potential antitumor VIVO complexes formed by flavonoid ligands. 2. Characterization of sulfonate derivatives of quercetin and morin, interaction with the bioligands of the plasma and preliminary biotransformation studies 114
Interaction of VVO2−hydrazonates with lysozyme 113
Oxovanadium(IV) complexes with pyrazinecarboxylic acids: The coordinating properties of ligands with the (N-aromatic, COO-) donor set 113
Determination of the hyperfine coupling constant and zero-field splitting in the ESR spectrum of Mn2+ in calcite 113
New developments in the comprehension of the biotransformation and transport of insulin-enhancing vanadium compounds in the blood serum 113
Vanadium 113
Coordination ability and biological activity of a naringenin thiosemicarbazone 113
Interaction between the low molecular mass components of blood serum and the VO(IV)-DHP system (DHP=1,2-dimethyl-3-hydroxy-4(1H)-pyridinone) 113
Synthesis, structural aspects and magnetic properties of an unusual 2D thiocyanato-bridged cobalt(II)-Schiff base network 113
A Series of Non-Oxido VIVComplexes of Dibasic ONS Donor Ligands: Solution Stability, Chemical Transformations, Protein Interactions, and Antiproliferative Activity 112
Synthesis, Characterisation and Insulin-Mimetic Activity of Oxovanadium(IV) Complexes with Amidrazone Derivatives 112
Design of nalidixic acid‑vanadium complex loaded into chitosan hybrid nanoparticles as smart strategy to inhibit bacterial growth and quorum sensing 112
Bulky bis(imidazole) and 2-sulfoterephthalate Assisted 3-D Cu(II) and 2-D Mn(II) Coordination Polymers: Topology, Diversity in Metal Containing Nodes and Spectral Elucidation 112
Synthesis and characterization of the chemical properties of new classes of NO donors as potential dopamine releasers in the treatment of Parkinson’s disease 112
Copper(II) complexes of imidazolinone herbicides 111
Unveiling VIVO2+ Binding Modes to Human Serum Albumins by an Integrated Spectroscopic–Computational Approach 111
Enhancement of dopamine release induced by new class of nitric oxide donor derived from piloty acid: an in vitro microdialysis study 110
Thermodynamic Study of Oxidovanadium(IV) with Kojic Acid Derivatives: A Multi-Technique Approach 110
Ternary complex formation between VO(IV)-picolinic acid or VO(IV)-6-methylpicolinic acid and small blood serum bioligands 110
Totale 13.422
Salva come PNG Salva come JPEG
Categoria #
all - tutte 110.948
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 110.948
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022856 0 0 1 13 41 26 47 83 103 54 95 393
2022/20232.201 231 140 45 392 214 388 2 268 380 18 72 51
2023/2024538 122 74 16 37 87 25 8 17 8 5 52 87
2024/20256.599 47 73 374 113 225 244 525 1.312 2.340 866 274 206
2025/202610.494 313 2.232 2.412 1.252 801 588 1.376 300 390 494 262 74
2026/2027923 278 645 0 0 0 0 0 0 0 0 0 0
Totale 26.022